Kura Oncology, Inc.
KURA
$6.02
$0.071.18%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -181.89M | -173.98M | -197.55M | -181.75M | -168.09M |
| Total Depreciation and Amortization | 855.00K | 848.00K | 858.00K | 866.00K | 877.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 21.23M | 21.28M | 19.95M | 19.25M | 19.24M |
| Change in Net Operating Assets | 271.04M | 286.17M | 7.63M | 6.93M | 10.18M |
| Cash from Operations | 111.23M | 134.32M | -169.12M | -154.71M | -137.80M |
| Capital Expenditure | -680.00K | -472.00K | -116.00K | -136.00K | -216.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -106.98M | -101.12M | 35.68M | -1.28M | -90.69M |
| Cash from Investing | -107.66M | -101.59M | 35.56M | -1.42M | -90.91M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 6.19M | 154.42M | 154.30M | 152.18M | 243.15M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 6.19M | 154.42M | 154.30M | 152.18M | 243.15M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 9.76M | 187.14M | 20.74M | -3.94M | 14.45M |